- MyIllumina
- Tools
-
Sequencing 500 genomes
HiSeq will be used to generate sequence data for the 500 genomes.
Read More » -
Enabling high-throughput counting applications
Exponential growth in the number of reads per run are empowering new studies.
View Presentation »
-
Advancements in the study of cancer genomics
Researchers are making new insights into cancer progression, diagnosis, and treatment.
Learn More » -
Exome sequencing supports a de novo mutational paradigm for schizophrenia
HiSeq helps researchers link de novo mutations with schizophrenia.
Read article »
Sequencing publications using Illumina technology
Get HiSeq 2000 Updates
Join the conversation
Keep up-to-date with the latest online conversation surrounding HiSeq.
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.